In long-term adriamycin-treated breast cancer cells, TRPC5-mediated Ca2+ influx promoted HIF-1α translocation in the nucleus and therefore the downstream transcription of HIF-1α-regulated VEGF expression, highlighting its contribution to promoting breast cancer angiogenesis [121] (Table 2 and Figure 2). Here, TRPC5 is linked to breast carcinoma.